生物股份
(600201)
| 流通市值：133.20亿 | | | 总市值：133.20亿 |
| 流通股本：11.00亿 | | | 总股本：11.00亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 1,249,770,267.26 | 756,440,407.6 | 346,463,052.95 | 1,396,413,685.47 |
| 营业总成本 | 942,963,509.65 | 612,971,608.14 | 269,670,737.42 | 1,278,271,814.19 |
| 其他经营收益 | | | | |
| 营业利润 | 284,432,487.92 | 130,734,736.52 | 97,538,962.66 | 104,771,240 |
| 利润总额 | 283,299,400.15 | 130,629,378.54 | 96,686,207.01 | 104,619,896.61 |
| 净利润 | 239,789,843.74 | 111,428,521.69 | 81,698,540.73 | 95,506,309.32 |
| 每股收益 | | | | |
| 其他综合收益 | -3,276.34 | -2,284.37 | -1,188.9 | 60,380,493.99 |
| 综合收益总额 | 239,786,567.4 | 111,426,237.32 | 81,697,351.83 | 155,886,803.31 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 2,865,824,448.17 | 2,823,600,134.56 | 2,375,140,038.79 | 2,343,742,348.27 |
| 非流动资产: | | | | |
| 非流动资产合计 | 3,750,356,954.76 | 3,793,170,656.01 | 4,161,795,416.65 | 4,267,829,898.78 |
| 资产总计 | 6,616,181,402.93 | 6,616,770,790.57 | 6,536,935,455.44 | 6,611,572,247.05 |
| 流动负债: | | | | |
| 流动负债合计 | 645,891,660.65 | 670,177,905.05 | 648,311,888.37 | 720,530,437.02 |
| 非流动负债: | | | | |
| 非流动负债合计 | 582,565,480.3 | 420,605,880.15 | 324,564,981.89 | 340,180,576.68 |
| 负债合计 | 1,228,457,140.95 | 1,090,783,785.2 | 972,876,870.26 | 1,060,711,013.7 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 5,266,171,740.27 | 5,411,031,288.79 | 5,461,324,776.38 | 5,368,046,822.74 |
| 股东权益合计 | 5,387,724,261.98 | 5,525,987,005.37 | 5,564,058,585.18 | 5,550,861,233.35 |
| 负债和股东权益合计 | 6,616,181,402.93 | 6,616,770,790.57 | 6,536,935,455.44 | 6,611,572,247.05 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,173,429,016.08 | 669,771,958.43 | 280,107,972.38 | 1,491,582,223.12 |
| 经营活动现金流出小计 | 959,116,613.16 | 618,748,108.46 | 268,700,017.53 | 1,175,465,363.02 |
| 经营活动产生的现金流量净额 | 214,312,402.92 | 51,023,849.97 | 11,407,954.85 | 316,116,860.1 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 1,465,089,416.75 | 725,429,624.86 | 513,834,646.24 | 521,557,492.74 |
| 投资活动现金流出小计 | 1,286,986,067.52 | 683,326,662.69 | 478,858,503.16 | 727,410,324.62 |
| 投资活动产生的现金流量净额 | 178,103,349.23 | 42,102,962.17 | 34,976,143.08 | -205,852,831.88 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 273,284,440 | 100,870,600 | - | 10,702,670 |
| 筹资活动现金流出小计 | 485,918,047.64 | 213,539,554.52 | 71,697,278.99 | 318,145,960.58 |
| 筹资活动产生的现金流量净额 | -212,633,607.64 | -112,668,954.52 | -71,697,278.99 | -307,443,290.58 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | 179,782,144.51 | -19,542,142.38 | -25,313,181.06 | -197,179,262.36 |
| 期末现金及现金等价物余额 | 796,527,255.67 | 597,202,968.78 | 591,431,930.1 | 616,745,111.16 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -19,542,142.38 | - | -197,179,262.36 |